Keytruda subkutan 790 mg/4.8 ml, Injektionslösung

7680702530024 CH-70253 Injektionslösung

Associated product:

KEYTRUDA subkutan 790 mg/4.8 ml sol inj 790 mg 1 p

No image available

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
04/06/2026
Summary of Product Characteristics
Français
04/06/2026
Summary of Product Characteristics
Italien
04/06/2026

Detailed composition

Substance Quantity Type Category
pembrolizumabum
790.0 MG Substance Wirkstoff (Principe actif)
berahyaluronidasum alfa
- Substance HNIDK
natrii chloridum
- Substance HNIDK
natrium
45.0 UG Substance HBESI
histidinum
- Substance HNIDK
histidini hydrochloridum monohydricum
- Substance HNIDK
methioninum
- Substance HIMDK
saccharum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Reimbursement information

Public price
CHF 8378.85
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/08/2026

Authorization holder

MSD Merck Sharp & Dohme AG

6005 Luzern

Authorization information

Swissmedic authorization number
70253
Drug name
Keytruda subkutan, Injektionslösung
Galenic form
LSINJ
ATC Code
L01FF02
Authorization status
Z
Dispensing category
A
First authorization
01/06/2026
Authorization expiration date
31/05/2031
IT Number
07.16.1.
Domain
Human medicine
Field of application
Melanom, Nicht-kleinzelliges Lungenkarzinom, Malignes Pleuramesotheliom, Kopf- und Halskarzinom, Klassisches Hodgkin Lymphom, B-Zell-Lymphom, Magenkarzinom, Urothelkarzinom, Tumore mit hoher Mikrosatelliteninstabilität, Kolorektales Karzinom, Biliäres Karzinom, Nierenzellkarzinom, Triple-negatives Mammakarzinom, Endometriumkarzinom, Zervixkarzinom

Package details

Description (FR)
KEYTRUDA subkutan 790 mg/4.8 ml sol inj 790 mg 1 p
Description (DE)
KEYTRUDA subkutan 790 mg/4.8 ml Inj Lös 790 mg 1 S
Market launch
01/08/2026
Narcotic (BTM)
No

Other package sizes (1)

KEYTRUDA subkutan 395 mg/2.4 ml sol inj 395 mg 1 p
1 DUR
GTIN: 7680702530017
View
Buy us a coffee Explore the data